- not yet recruiting
IBM Dietary Surveillance Study
This study looks at how diet might affect people with Inclusion Body Myositis (IBM). Researchers want to see if food choices can influence muscle health and daily abilities in those with IBM, comparing them to healthy adults.
United Kingdom - enrolling by invitationNA
The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.
This study looks at how walking aids and training can help people with certain muscle and nerve conditions fall less often. It aims to improve their safety and daily life by finding the best ways to use these aids.
Germany - ongoing, recruitingPhase II and Phase III (Integrated)
A Phase II/III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Determine the Efficacy and Safety of ABC008 in the Treatment of Subjects with Inclusion Body Myositis
This study is testing a new medicine called Ulviprubart for Inclusion Body Myositis (IBM). It aims to see if the medicine is safe and helps improve muscle strength and daily activities for people with IBM over 76 weeks, compared to a dummy treatment.
Belgium · Germany · France